{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:23:30Z","timestamp":1792452210619,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.survophthal.2025.03.009","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:55:47Z","timestamp":1743252947000},"page":"868-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Primary ocular, adnexal, and orbital rhabdomyosarcoma: A review"],"prefix":"10.1016","volume":"70","author":[{"given":"Ayushi","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijitha S.","family":"Vempuluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-9961","authenticated-orcid":false,"given":"Swathi","family":"Kaliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00330-008-1123-6","article-title":"Characterization of pediatric head and neck masses with diffusion-weighted MR imaging","volume":"19","author":"Abdel Razek","year":"2009","journal-title":"Eur Radio"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0161-6420(79)35394-5","article-title":"The treatment of orbital rhabdomyosarcoma with irradiation and chemotherapy","volume":"86","author":"Abramson","year":"1979","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2025.03.009_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/gcc.22187","article-title":"Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis","volume":"53","author":"Agaram","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.survophthal.2025.03.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01676830.2024.2333354","article-title":"Primary orbital and adnexal rhabdomyosarcoma: a study of 54 Asian Indian patients","author":"Agarwal","year":"2024","journal-title":"Orbit"},{"issue":"10","key":"10.1016\/j.survophthal.2025.03.009_bib5","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/jor.24387","article-title":"Epidemiology, incidence, and survival of rhabdomyosarcoma subtypes: SEER and ICES database analysis","volume":"37","author":"Amer","year":"2019","journal-title":"J Orthop Res"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pbc.25862","article-title":"Histology, fusion status, and outcome in alveolar rhabdomyosarcoma with low-risk clinical features: A report from the Children's Oncology Group","volume":"63","author":"Arnold","year":"2016","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000536382","article-title":"Primary Conjunctival embryonal rhabdomyosarcoma in an 8-year-old girl","volume":"15","author":"Bakhtiary","year":"2024","journal-title":"Case Rep Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib8","first-page":"284","article-title":"Rhabdomyosarcoma in Karachi 1998-2002","volume":"5","author":"Bhurgri","year":"2004","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib9","first-page":"561","article-title":"Orbital embryonal rhabdomyosarcoma in Karachi (1998-2002)","volume":"54","author":"Bhurgri","year":"2004","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib10","first-page":"129","article-title":"Clinical, ultrasonographic and CT evaluation of orbital rhabdomyosarcomas with management","volume":"39","author":"Boparai","year":"1991","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MPH.0000000000000245","article-title":"Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy","volume":"36","author":"Boutroux","year":"2014","journal-title":"J Pedia Hematol Oncol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib12","first-page":"119","article-title":"Clinical management of orbital rhabdomyosarcoma in a referral center in Spain","volume":"53","author":"Bravo-Ljubetic","year":"2016","journal-title":"J AAPOS"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00043426-200308000-00014","article-title":"Embryonal rhabdomyosarcoma presenting as conjunctival tumor","volume":"25","author":"Brichard","year":"2003","journal-title":"J Pedia Hematol Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib14","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archopht.1986.01050200109062","article-title":"Wick MR. Embryonal rhabdomyosarcoma of the conjunctiva. A clinicopathologic and immunohistochemical study","volume":"104","author":"Cameron","year":"1986","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13244-022-01351-z","article-title":"Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?","volume":"14","author":"Chatziantoniou","year":"2023","journal-title":"Insights Imaging"},{"key":"10.1016\/j.survophthal.2025.03.009_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68221","article-title":"Defining function of wild-type and three patient-specific TP53 mutations in a zebrafish model of embryonal rhabdomyosarcoma","volume":"12","author":"Chen","year":"2023","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.survophthal.2025.03.009_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1200\/JCO.2010.32.1984","article-title":"Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy","volume":"29","author":"Chisholm","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2350\/08-03-0434.1","article-title":"ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status","volume":"12","author":"Corao","year":"2009","journal-title":"Pedia Dev Pathol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1067\/mpa.2000.107897","article-title":"Orbital abscess masquerading as a rhabdomyosarcoma","volume":"4","author":"Cota","year":"2000","journal-title":"J aapos"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29644","article-title":"Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group","volume":"69","author":"Crane","year":"2022","journal-title":"Pedia Blood Cancer"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib21","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1200\/JCO.2001.19.12.3091","article-title":"Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease","volume":"19","author":"Crist","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1200\/JCO.1990.8.3.443","article-title":"Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee","volume":"8","author":"Crist","year":"1990","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.1995.13.3.610","article-title":"The Third Intergroup Rhabdomyosarcoma Study","volume":"13","author":"Crist","year":"1995","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib24","first-page":"2869","article-title":"Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma","volume":"54","author":"Davis","year":"1994","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib25","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/0002-9394(69)94588-7","article-title":"Management of orbital rhabdomyosarcoma","volume":"68","author":"Dayton","year":"1969","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0002-9440(10)64743-8","article-title":"Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass","volume":"156","author":"Dias","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib27","first-page":"26","article-title":"Rhabdomyosarcoma of head and neck in children","volume":"31","author":"Donaldson","year":"1973","journal-title":"Comb Treat Surg, Irradiat, Chemother Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ceo.12809","article-title":"Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma","volume":"45","author":"Eade","year":"2017","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib29","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archopht.1991.01080070094043","article-title":"Primary rhabdomyosarcoma of the iris","volume":"109","author":"Elsas","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2025.03.009_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pbc.26540","article-title":"45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"64","author":"Ermoian","year":"2017","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30470-9","article-title":"A rare location of palpebral rhabdomyosarcoma","volume":"19","author":"Essafi","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5858\/arpa.2021-0183-RA","article-title":"An integrative morphologic and molecular approach for diagnosis and subclassification of rhabdomyosarcoma","volume":"146","author":"Fan","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib33","first-page":"165","article-title":"Pattern of presentation and outcome of ophthalmic rhabdomyosarcoma in Ibadan","volume":"42","author":"Fasina","year":"2013","journal-title":"Afr J Med Med Sci"},{"issue":"24","key":"10.1016\/j.survophthal.2025.03.009_bib34","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.3390\/cancers14246060","article-title":"Shedding a light on the challenges of adolescents and young adults with rhabdomyosarcoma","volume":"14","author":"Ferrari","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib35","first-page":"1208","article-title":"Orbital cavitary rhabdomyosarcoma masquerading as lymphangioma","volume":"119","author":"Fetkenhour","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1440-1673.2005.01526.x","article-title":"Orbital rhabdomyosarcoma: multidisciplinary treatment experience","volume":"50","author":"Forstner","year":"2006","journal-title":"Austral Radio"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archopht.1959.04220020029004","article-title":"Embryonal rhabdomyosarcoma of the orbit in children and young adults","volume":"62","author":"Frayer","year":"1959","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/modpathol.3880357","article-title":"Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers","volume":"14","author":"Furlong","year":"2001","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ng1193-230","article-title":"Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma","volume":"5","author":"Galili","year":"1993","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib40","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.7314\/APJCP.2013.14.8.4641","article-title":"Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma","volume":"14","author":"Ge","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1593\/neo.05829","article-title":"Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors","volume":"8","author":"Goldstein","year":"2006","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S1470-2045(24)00255-9","article-title":"Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group","volume":"25","author":"Gupta","year":"2024","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002340000464","article-title":"The \"botryoid sign\": a characteristic feature of rhabdomyosarcomas in the head and neck","volume":"43","author":"Hagiwara","year":"2001","journal-title":"Neuroradiology"},{"issue":"319","key":"10.1016\/j.survophthal.2025.03.009_bib44","first-page":"23","article-title":"An unusual localization of rhabdomyosarcoma: about a case report","author":"Hajji","year":"2012","journal-title":"Bull Soc Belg Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.239","article-title":"Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells","volume":"8","author":"Haydn","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canlet.2014.04.021","article-title":"Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA","volume":"351","author":"Heinicke","year":"2014","journal-title":"Cancer Lett"},{"issue":"14","key":"10.1016\/j.survophthal.2025.03.009_bib47","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1002\/cam4.2504","article-title":"Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group","volume":"8","author":"Hibbitts","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.survophthal.2025.03.009_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(195801\/02)11:1<181::AID-CNCR2820110130>3.0.CO;2-I","article-title":"Rhabdomyosarcoma: a clinicopathological study and classification of 39 cases","volume":"11","author":"Horn","year":"1958","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib49","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.20711","article-title":"Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens","volume":"101","author":"Hostein","year":"2004","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib50","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/pbc.22434","article-title":"Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group","volume":"54","author":"Huh","year":"2010","journal-title":"Pedia Blood Cancer"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib51","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1148\/radiol.2452061535","article-title":"Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity","volume":"245","author":"Humphries","year":"2007","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/ceo.12282","article-title":"Adult ocular adnexal rhabdomyosarcoma presenting with inferior fornix lesion without proptosis","volume":"42","author":"Inglis","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib53","first-page":"3395","article-title":"Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models","volume":"119","author":"JGt","year":"2009","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12105-022-01425-w","article-title":"Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors","volume":"16","author":"Jo","year":"2022","journal-title":"Head Neck Pathol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0002-9394(66)91210-4","article-title":"Orbital rhabdomyosarcoma","volume":"61","author":"Jones","year":"1966","journal-title":"Anal 62 cases Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib56","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.4103\/ijo.IJO_79_22","article-title":"Rhabdomyosarcoma masquerading as orbital cellulitis","volume":"70","author":"Joshi","year":"2022","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaapos.2010.04.008","article-title":"Lower eyelid rhabdomyosarcoma in a 3-month-old infant","volume":"14","author":"Jung","year":"2010","journal-title":"J AAPOS"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.sjopt.2013.06.004","article-title":"Orbital rhabdomyosarcomas: A review","volume":"27","author":"Jurdy","year":"2013","journal-title":"Saudi J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/eye.2011.9","article-title":"Incidence of primary malignant orbital tumours in the Netherlands","volume":"25","author":"Koopman","year":"2011","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib60","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00247-024-05933-5","article-title":"Bone marrow disease in rhabdomyosarcoma visualized by 2-[(18)F]fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"54","author":"Kr\u00f6ning","year":"2024","journal-title":"Pedia Radio"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1034\/j.1600-0420.2000.078006717.x","article-title":"Rhabdomyosarcoma presenting as subconjunctival tumour","volume":"78","author":"Kuchar","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2025.03.009_bib62","article-title":"Epidemiology, trends, and survival of ocular and orbital rhabdomyosarcoma: a nationwide study in the USA (1996-2018): Ocular and orbital rhabdomyosarcoma in the USA","author":"Kunbaz","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"15","key":"10.1016\/j.survophthal.2025.03.009_bib63","first-page":"5749","article-title":"Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro","volume":"9","author":"Kutko","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib64","first-page":"1165","article-title":"Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group","volume":"80","author":"Lawrence","year":"1997","journal-title":"Child'S Cancer Study Group Pediatr Oncol Group Cancer"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib65","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1097\/IOP.0000000000000290","article-title":"Congenital eyelid rhabdomyosarcoma","volume":"32","author":"Lee","year":"2016","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jclinpath-2013-201655","article-title":"Prognostic implications of anaplastic lymphoma kinase gene aberrations in rhabdomyosarcoma; an immunohistochemical and fluorescence in situ hybridisation study","volume":"67","author":"Lee","year":"2014","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib67","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0002-9394(68)93104-8","article-title":"Subconjunctival rhabdomyosarcoma","volume":"65","author":"Levy","year":"1968","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2009.02.011","article-title":"Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma","volume":"192","author":"Li","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib69","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/1097-0142(19810301)47:5<1023::AID-CNCR2820470533>3.0.CO;2-A","article-title":"Infections in children with malignant disease in Argentina","volume":"47","author":"L\u00f3pez","year":"1981","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib70","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0161-6420(97)30162-6","article-title":"Multidisciplinary management of refractory orbital rhabdomyosarcoma","volume":"104","author":"Mannor","year":"1997","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib71","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3390\/ijms23073581","article-title":"Bromodomain inhibitor JQ1 provides novel insights and perspectives in rhabdomyosarcoma treatment","volume":"23","author":"Marchesi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib72","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/jcp.26107","article-title":"12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells","volume":"233","author":"Marchesi","year":"2018","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L","article-title":"The Intergroup Rhabdomyosarcoma Study-I. A final report","volume":"61","author":"Maurer","year":"1988","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib74","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/1097-0142(19930301)71:5<1904::AID-CNCR2820710530>3.0.CO;2-X","article-title":"The Intergroup Rhabdomyosarcoma Study-II","volume":"71","author":"Maurer","year":"1993","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.21138","article-title":"Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma","volume":"104","author":"Mazzoleni","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S0004-27492012000300012","article-title":"Embryonal rhabdomyosarcoma of the caruncle in a 4 year-old boy: case report","volume":"75","author":"Mendez","year":"2012","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.survophthal.2025.03.009_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejca.2021.07.006","article-title":"Role of (18)F-FDG-PET\/CT in the staging of metastatic rhabdomyosarcoma: a report from the European pediatric Soft tissue sarcoma Study Group","volume":"155","author":"Mercolini","year":"2021","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib78","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/cncr.34723","article-title":"Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group","volume":"129","author":"Metts","year":"2023","journal-title":"Cancer"},{"issue":"24","key":"10.1016\/j.survophthal.2025.03.009_bib79","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","article-title":"Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group","volume":"24","author":"Meza","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3-4","key":"10.1016\/j.survophthal.2025.03.009_bib80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000530730","article-title":"WHO Classification of Tumours Editorial Board. The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit","volume":"9","author":"Milman","year":"2023","journal-title":"Ocul Oncol Pathol"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib81","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.1987.5.8.1191","article-title":"Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults","volume":"5","author":"Miser","year":"1987","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.survophthal.2025.03.009_bib82","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2011.38.5591","article-title":"PAX3\/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification","volume":"30","author":"Missiaglia","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib83","article-title":"Primary conjunctival rhabdomyosarcoma in a pediatric patient","volume":"11","author":"Morales","year":"2019","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib84","first-page":"6","article-title":"Magnetic resonance imaging and DWI features of orbital rhabdomyosarcoma","volume":"29","author":"Mu","year":"2014","journal-title":"Eye Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib85","first-page":"6213","article-title":"Adult pleomorphic rhabdomyosarcoma: A multicentre retrospective study","volume":"35","author":"Noujaim","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.2001.19.1.197","article-title":"Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop","volume":"19","author":"Oberlin","year":"2001","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.survophthal.2025.03.009_bib87","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2011.40.3287","volume":"30","author":"Oberlin","year":"2012","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.survophthal.2025.03.009_bib88","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/cncr.24465","article-title":"Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005","volume":"115","author":"Ognjanovic","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib89","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/jcm10071416","article-title":"Prioritization of novel agents for patients with rhabdomyosarcoma: A report from the Children's Oncology Group (COG) new agents for rhabdomyosarcoma task force","volume":"10","author":"Pacenta","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.survophthal.2025.03.009_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101124","article-title":"Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics","volume":"25","author":"Pal","year":"2019","journal-title":"Redox Biol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib91","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAP.0b013e3182a92d0d","article-title":"Classification of rhabdomyosarcoma and its molecular basis","volume":"20","author":"Parham","year":"2013","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/meajo.MEAJO_8_18","article-title":"Botryoid rhabdomyosarcoma of the conjunctiva in a young boy","volume":"25","author":"Pennington","year":"2018","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132330","article-title":"Understanding the interplay between expression, mutation and activity of ALK receptor in rhabdomyosarcoma cells for clinical application of small-molecule inhibitors","volume":"10","author":"Peron","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib94","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00417-005-0085-5","article-title":"A case of primary botryoid conjunctival rhabdomyosarcoma","volume":"244","author":"Polito","year":"2006","journal-title":"Graefe'S Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2025.03.009_bib95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00957027","article-title":"Rhabdomyosarcoma of the orbit; a clinicopathologic study of 55 cases","volume":"335","author":"Porterfield","year":"1962","journal-title":"Virchows Arch Pathol Anat Physiol Klin Med"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib96","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archophthalmol.2012.313","article-title":"Caruncular alveolar rhabdomyosarcoma in a woman previously treated for breast cancer","volume":"130","author":"Ramstead","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/(SICI)1096-911X(200006)34:6<413::AID-MPO6>3.0.CO;2-4","article-title":"Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991","volume":"34","author":"Raney","year":"2000","journal-title":"Med Pedia Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib98","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/pbc.24289","article-title":"Outcome of patients with localized orbital sarcoma who relapsed following treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III and -IV, 1984-1997: a report from the Children's Oncology Group","volume":"60","author":"Raney","year":"2013","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/13577140120048890","article-title":"The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols","volume":"5","author":"Raney","year":"2001","journal-title":"Sarcoma"},{"issue":"10","key":"10.1016\/j.survophthal.2025.03.009_bib100","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1200\/JCO.2010.30.4469","volume":"29","author":"Raney","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib101","article-title":"Clinical characteristics and outcomes of infants compared with children diagnosed with rhabdomyosarcoma: Analysis of surveillance, epidemiology and end results data from 2000 to 2016","volume":"5","author":"Rees","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib102","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2016.144","article-title":"MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes","volume":"29","author":"Rekhi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.survophthal.2025.03.009_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fonc.2015.00130","article-title":"Hedgehog inhibitors in rhabdomyosarcoma: A comparison of four compounds and responsiveness of four cell lines","volume":"5","author":"Ridzewski","year":"2015","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib104","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/mpo.2950170308","article-title":"An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP)","volume":"17","author":"Rodary","year":"1989","journal-title":"Med Pedia Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib105","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/PAS.0000000000000195","article-title":"Myogenin, AP2\u03b2, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group","volume":"38","author":"Rudzinski","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib106","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28798","article-title":"Pathology of childhood rhabdomyosarcoma: A consensus opinion document from the Children's Oncology Group, European Paediatric Soft Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe","volume":"68","author":"Rudzinski","year":"2021","journal-title":"Pedia Blood Cancer"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib107","first-page":"31","article-title":"The treatment of orbital rhabdomyosarcoma of children with primary radiation therapy","volume":"114","author":"Sagerman","year":"1972","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib108","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archopht.1972.01000020648007","article-title":"Alveolar rhabdomyosarcoma of the eyelid. Diagnosis by electron microscopy","volume":"87","author":"Schuster","year":"1972","journal-title":"Arch Ophthalmol"},{"issue":"19","key":"10.1016\/j.survophthal.2025.03.009_bib109","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.1073\/pnas.86.19.7480","article-title":"A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting","volume":"86","author":"Scrable","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s004170050173","article-title":"Primary conjunctival rhabdomyosarcoma: 2.5 years' follow-up after combined chemotherapy and brachytherapy","volume":"236","author":"Sekundo","year":"1998","journal-title":"Graefe'S Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib111","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1097-0142(197708)40:2<744::AID-CNCR2820400223>3.0.CO;2-R","article-title":"Growing human sarcomas in culture","volume":"40","author":"Sethi","year":"1977","journal-title":"Cancer"},{"issue":"26","key":"10.1016\/j.survophthal.2025.03.009_bib112","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1200\/JCO.20.03060","article-title":"Genomic classification and clinical outcome in rhabdomyosarcoma: A report from an international consortium","volume":"39","author":"Shern","year":"2021","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib113","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0161-6420(01)00840-5","article-title":"Clinical spectrum of primary ophthalmic rhabdomyosarcoma","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2025.03.009_bib114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0039-6257(02)00415-0","article-title":"Rhabdomyosarcoma: review for the ophthalmologist","volume":"48","author":"Shields","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1078-0432.CCR-11-2056","article-title":"Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways","volume":"18","author":"Shukla","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/01676830903207802","article-title":"Orbital cavitary rhabdomyosarcoma: a diagnostic dilemma","volume":"29","author":"Silvana","year":"2010","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2025.03.009_bib117","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejca.2021.10.031","article-title":"Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study","volume":"160","author":"Slater","year":"2022","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.eye.6702528","article-title":"Conjunctival rhabdomyosarcoma presenting as a squamous papilloma","volume":"21","author":"Smith","year":"2007","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib119","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0009-9260(98)80009-3","article-title":"Orbital rhabdomyosarcoma-the radiological characteristics","volume":"53","author":"Sohaib","year":"1998","journal-title":"Clin Radio"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib120","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.2002.03.137","article-title":"PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group","volume":"20","author":"Sorensen","year":"2002","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib121","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2005.08.130","article-title":"Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89","volume":"23","author":"Stevens","year":"2005","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.survophthal.2025.03.009_bib122","first-page":"6324","article-title":"Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction","volume":"49","author":"Stratton","year":"1989","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib123","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ophtha.2023.09.027","article-title":"Conjunctival spindle cell\/sclerosing rhabdomyosarcoma","volume":"131","author":"Su","year":"2024","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.survophthal.2025.03.009_bib124","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1200\/JCO.2008.19.7483","article-title":"Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients","volume":"27","author":"Sultan","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/path.4307","article-title":"Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma","volume":"232","author":"Szuhai","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.survophthal.2025.03.009_bib126","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2147\/CMAR.S163932","article-title":"The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study","volume":"10","author":"Tang","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10.1016\/j.survophthal.2025.03.009_bib127","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archopht.120.5.668","article-title":"Primary conjunctival rhabdomyosarcoma","volume":"120","author":"Taylor","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib128","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S1470-2045(16)00162-5","article-title":"Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5","volume":"17","author":"Trama","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3-4","key":"10.1016\/j.survophthal.2025.03.009_bib129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0165-4608(86)90069-5","article-title":"Consistent chromosomal translocation in alveolar rhabdomyosarcoma","volume":"19","author":"Turc-Carel","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"issue":"6","key":"10.1016\/j.survophthal.2025.03.009_bib130","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0194599811417063","article-title":"Head and neck rhabdomyosarcoma: A critical analysis of population-based incidence and survival data","volume":"145","author":"Turner","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0189-6725.41631","article-title":"Clinical characteristics and outcome of surgical treatment of childhood rhabdomyosarcoma: a 7-year experience","volume":"5","author":"Uba","year":"2008","journal-title":"Afr J Paediatr Surg"},{"issue":"7","key":"10.1016\/j.survophthal.2025.03.009_bib132","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0161-6420(03)00457-3","article-title":"Downgaze \"hang-up\" of the upper eyelid in patients with adult-onset ptosis: An important sign of possible orbital malignancy","volume":"110","author":"Uddin","year":"2003","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2025.03.009_bib133","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/DAD.0000000000001560","article-title":"Epithelioid rhabdomyosarcoma: Report of a cutaneous case and literature review of a recently described variant of rhabdomyosarcoma","volume":"42","author":"Val\u00e9rio","year":"2020","journal-title":"Am J Derm"},{"issue":"12","key":"10.1016\/j.survophthal.2025.03.009_bib134","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1007\/s00247-023-05745-z","article-title":"Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee","volume":"53","author":"van Ewijk","year":"2023","journal-title":"Pedia Radio"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib135","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2011.37.8588","article-title":"Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications","volume":"30","author":"van Gaal","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib136","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.critrevonc.2011.06.005","article-title":"Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead","volume":"82","author":"Van Gaal","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/IJO.IJO_495_23","article-title":"Clinical spectrum and clinicopathological correlation of pediatric orbital tumors: 20 years' experience from a tertiary eye care center","volume":"72","author":"Vijay","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"16","key":"10.1016\/j.survophthal.2025.03.009_bib138","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1158\/0008-5472.CAN-04-0844","article-title":"Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1","volume":"64","author":"Wachtel","year":"2004","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.survophthal.2025.03.009_bib139","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1634\/theoncologist.12-8-1007","article-title":"The biology behind mTOR inhibition in sarcoma","volume":"12","author":"Wan","year":"2007","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0161-6420(87)33464-5","article-title":"Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee","volume":"94","author":"Wharam","year":"1987","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2025.03.009_bib141","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0161-6420(90)32386-2","article-title":"Rhabdomyosarcoma of the ciliary body","volume":"97","author":"Wilson","year":"1990","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib142","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bjo.56.1.60","article-title":"Rhabdomyosarcoma of the iris. Report of the first recorded case","volume":"56","author":"Woyke","year":"1972","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2025.03.009_bib143","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/IOP.0b013e31828de376","article-title":"Orbital cavitary rhabdomyosarcoma: case report and literature review","volume":"30","author":"Yaz\u0131c\u0131","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib144","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bjc.2014.471","article-title":"New insights into signalling-pathway alterations in rhabdomyosarcoma","volume":"112","author":"Zhu","year":"2015","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.survophthal.2025.03.009_bib145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/PAS.0000000000000105","article-title":"Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study","volume":"38","author":"Zin","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.survophthal.2025.03.009_bib146","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/aos.14596","article-title":"Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma","volume":"99","author":"Zloto","year":"2021","journal-title":"Acta Ophthalmol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725000608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625725000608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:29:21Z","timestamp":1762219761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625725000608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":146,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0039625725000608"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.03.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary ocular, adnexal, and orbital rhabdomyosarcoma: A review","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2025.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}